CD6 is a target for cancer immunotherapy.
Ruth JH, Gurrea-Rubio M, Athukorala KS, Rasmussen SM, Weber DP, Randon PM, Gedert RJ, Lind ME, Amin MA, Campbell PL, Tsou PS, Mao-Draayer Y, Wu Q, Lanigan TM, Keshamouni VG, Singer NG, Lin F, Fox DA.
Ruth JH, et al.
JCI Insight. 2021 Mar 8;6(5):e145662. doi: 10.1172/jci.insight.145662.
JCI Insight. 2021.
PMID: 33497367
Free PMC article.